INDO US BIO-TECH | KOTYARK INDUSTRIES | INDO US BIO-TECH/ KOTYARK INDUSTRIES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 42.3 | - | - | View Chart |
P/BV | x | 8.6 | 20.5 | 42.2% | View Chart |
Dividend Yield | % | 0.0 | 0.4 | - |
INDO US BIO-TECH KOTYARK INDUSTRIES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDO US BIO-TECH Mar-23 |
KOTYARK INDUSTRIES Mar-23 |
INDO US BIO-TECH/ KOTYARK INDUSTRIES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 125 | NA | - | |
Low | Rs | 25 | NA | - | |
Sales per share (Unadj.) | Rs | 61.6 | 130.1 | 47.3% | |
Earnings per share (Unadj.) | Rs | 7.2 | 13.1 | 55.0% | |
Cash flow per share (Unadj.) | Rs | 8.0 | 14.2 | 56.7% | |
Dividends per share (Unadj.) | Rs | 0 | 5.00 | 0.0% | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 54.3 | 65.0 | 83.6% | |
Shares outstanding (eoy) | m | 10.03 | 8.73 | 114.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.2 | 0 | - | |
Avg P/E ratio | x | 10.4 | 0 | - | |
P/CF ratio (eoy) | x | 9.4 | 0 | - | |
Price / Book Value ratio | x | 1.4 | 0 | - | |
Dividend payout | % | 0 | 38.1 | 0.0% | |
Avg Mkt Cap | Rs m | 754 | 0 | - | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 13 | 5 | 274.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 617 | 1,136 | 54.4% | |
Other income | Rs m | 0 | 0 | 262.5% | |
Total revenues | Rs m | 618 | 1,136 | 54.4% | |
Gross profit | Rs m | 94 | 178 | 52.7% | |
Depreciation | Rs m | 8 | 9 | 89.2% | |
Interest | Rs m | 12 | 14 | 85.0% | |
Profit before tax | Rs m | 74 | 155 | 47.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1 | 41 | 3.6% | |
Profit after tax | Rs m | 72 | 115 | 63.2% | |
Gross profit margin | % | 15.2 | 15.7 | 96.9% | |
Effective tax rate | % | 2.0 | 26.1 | 7.6% | |
Net profit margin | % | 11.7 | 10.1 | 116.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 599 | 343 | 174.8% | |
Current liabilities | Rs m | 123 | 61 | 200.7% | |
Net working cap to sales | % | 77.1 | 24.8 | 311.2% | |
Current ratio | x | 4.9 | 5.6 | 87.1% | |
Inventory Days | Days | 1 | 69 | 2.0% | |
Debtors Days | Days | 146,261,410 | 393 | 37,212,262.9% | |
Net fixed assets | Rs m | 90 | 388 | 23.1% | |
Share capital | Rs m | 100 | 87 | 114.8% | |
"Free" reserves | Rs m | 445 | 480 | 92.6% | |
Net worth | Rs m | 545 | 567 | 96.1% | |
Long term debt | Rs m | 17 | 104 | 16.3% | |
Total assets | Rs m | 689 | 731 | 94.3% | |
Interest coverage | x | 7.2 | 12.0 | 59.7% | |
Debt to equity ratio | x | 0 | 0.2 | 17.0% | |
Sales to assets ratio | x | 0.9 | 1.6 | 57.7% | |
Return on assets | % | 12.3 | 17.6 | 69.6% | |
Return on equity | % | 13.3 | 20.2 | 65.8% | |
Return on capital | % | 15.3 | 25.2 | 60.7% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 5 | 18 | 29.7% | |
From Investments | Rs m | -67 | -297 | 22.5% | |
From Financial Activity | Rs m | 63 | 275 | 22.8% | |
Net Cashflow | Rs m | 1 | -4 | -34.4% |
Indian Promoters | % | 70.2 | 67.7 | 103.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 1.5 | - | |
FIIs | % | 0.0 | 0.9 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.8 | 32.4 | 92.2% | |
Shareholders | 1,166 | 3,121 | 37.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare INDO US BIO-TECH With: KAVERI SEED VENKYS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | INDO US BIO-TECH | KOTYARK INDUSTRIES |
---|---|---|
1-Day | 8.77% | 1.50% |
1-Month | 26.17% | 8.44% |
1-Year | 113.64% | 89.37% |
3-Year CAGR | 152.58% | 23.72% |
5-Year CAGR | 42.16% | 13.62% |
* Compound Annual Growth Rate
Here are more details on the INDO US BIO-TECH share price and the KOTYARK INDUSTRIES share price.
Moving on to shareholding structures...
The promoters of INDO US BIO-TECH hold a 70.2% stake in the company. In case of KOTYARK INDUSTRIES the stake stands at 67.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDO US BIO-TECH and the shareholding pattern of KOTYARK INDUSTRIES.
Finally, a word on dividends...
In the most recent financial year, INDO US BIO-TECH paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
KOTYARK INDUSTRIES paid Rs 5.0, and its dividend payout ratio stood at 38.1%.
You may visit here to review the dividend history of INDO US BIO-TECH, and the dividend history of KOTYARK INDUSTRIES.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.